224 related articles for article (PubMed ID: 19073452)
1. [Silymarin in the treatment of chronic liver diseases: past and future].
Fehér J; Lengyel G
Orv Hetil; 2008 Dec; 149(51):2413-8. PubMed ID: 19073452
[TBL] [Abstract][Full Text] [Related]
2. Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years.
Federico A; Dallio M; Loguercio C
Molecules; 2017 Jan; 22(2):. PubMed ID: 28125040
[TBL] [Abstract][Full Text] [Related]
3. Silymarin in the prevention and treatment of liver diseases and primary liver cancer.
Féher J; Lengyel G
Curr Pharm Biotechnol; 2012 Jan; 13(1):210-7. PubMed ID: 21466434
[TBL] [Abstract][Full Text] [Related]
4. [Oxidative stress and antioxidant defense in alcoholic liver disease and chronic hepatitis C].
Pár A; Róth E; Rumi G; Kovács Z; Nemes J; Mózsik G
Orv Hetil; 2000 Jul; 141(30):1655-9. PubMed ID: 10962902
[TBL] [Abstract][Full Text] [Related]
5. Silymarin as Supportive Treatment in Liver Diseases: A Narrative Review.
Gillessen A; Schmidt HH
Adv Ther; 2020 Apr; 37(4):1279-1301. PubMed ID: 32065376
[TBL] [Abstract][Full Text] [Related]
6. Silymarin: a review of its clinical properties in the management of hepatic disorders.
Wellington K; Jarvis B
BioDrugs; 2001; 15(7):465-89. PubMed ID: 11520257
[TBL] [Abstract][Full Text] [Related]
7. Chronic liver disease and oxidative stress - a narrative review.
Seen S
Expert Rev Gastroenterol Hepatol; 2021 Sep; 15(9):1021-1035. PubMed ID: 34176419
[No Abstract] [Full Text] [Related]
8. Hepatoprotective herbal drug, silymarin from experimental pharmacology to clinical medicine.
Pradhan SC; Girish C
Indian J Med Res; 2006 Nov; 124(5):491-504. PubMed ID: 17213517
[TBL] [Abstract][Full Text] [Related]
9. The Pros and the Cons for the Use of Silybin-Rich Oral Formulations in Treatment of Liver Damage (NAFLD in Particular).
Rosso N; Marin V; Giordani A; Persiani S; Sala F; Cavicchioli L; Rovati LC; Tiribelli C
Curr Med Chem; 2015; 22(25):2954-71. PubMed ID: 26219393
[TBL] [Abstract][Full Text] [Related]
10. Role of silymarin as antioxidant in clinical management of chronic liver diseases: a narrative review.
Aghemo A; Alekseeva OP; Angelico F; Bakulin IG; Bakulina NV; Bordin D; Bueverov AO; Drapkina OM; Gillessen A; Kagarmanova EM; Korochanskaya NV; Kucheryavii UA; Lazebnik LB; Livzan MA; Maev IV; Martynov AI; Osipenko MF; Sas EI; Starodubova A; Uspensky YP; Vinnitskaya EV; Yakovenko EP; Yakovlev AA
Ann Med; 2022 Dec; 54(1):1548-1560. PubMed ID: 35635048
[TBL] [Abstract][Full Text] [Related]
11. Effect of Liverubin™ on hepatic biochemical profile in patients of alcoholic liver disease: a retrospective study.
Nanda V; Gupta V; Sharma SN; Pasricha A; Karmakar AK; Patel A; Bhatt VM; Kantroo BL; Kumar B; Paul NK; Attam R
Minerva Med; 2014 Dec; 105(6 Suppl 2):1-8. PubMed ID: 26076375
[TBL] [Abstract][Full Text] [Related]
12. [Hepatoprotectors in therapy of the alcoholic liver disease (clinical and experimental research)].
Fedotova TF; Trubitsina IE
Eksp Klin Gastroenterol; 2011; (6):113-9. PubMed ID: 22168090
[TBL] [Abstract][Full Text] [Related]
13. Milk thistle in liver diseases: past, present, future.
Abenavoli L; Capasso R; Milic N; Capasso F
Phytother Res; 2010 Oct; 24(10):1423-32. PubMed ID: 20564545
[TBL] [Abstract][Full Text] [Related]
14. Effect of silybin on high-fat-induced fatty liver in rats.
Yao J; Zhi M; Minhu C
Braz J Med Biol Res; 2011 Jul; 44(7):652-9. PubMed ID: 21755261
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of alcoholic liver diseases. Abstinence, nutritional support, drug therapy, liver transplantation].
Pár A
Orv Hetil; 2000 Apr; 141(16):827-33. PubMed ID: 10817009
[TBL] [Abstract][Full Text] [Related]
16. Antioxidants as therapeutic agents for liver disease.
Singal AK; Jampana SC; Weinman SA
Liver Int; 2011 Nov; 31(10):1432-48. PubMed ID: 22093324
[TBL] [Abstract][Full Text] [Related]
17. [Drug clinics. Drug of the month. Legalon (silymarin)].
Luyckx F; Scheen AJ
Rev Med Liege; 1997 Dec; 52(12):792-6. PubMed ID: 9481179
[No Abstract] [Full Text] [Related]
18. [Treatment of alcoholic liver disease].
Fehér J; Krisztina H
Orv Hetil; 2003 Jun; 144(26):1305-6. PubMed ID: 12894675
[No Abstract] [Full Text] [Related]
19. [Clinical experience with silymarin in the treatment of chronic liver disease(author's transl)].
Reutter FW; Haase W
Schweiz Rundsch Med Prax; 1975 Sep; 64(36):1145-51. PubMed ID: 1099576
[No Abstract] [Full Text] [Related]
20. [Antioxidant therapy in chronic liver diseases].
Lengyel G; Tulassay Z
Orv Hetil; 2006 Jun; 147(24):1113-8. PubMed ID: 16865855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
